Fig. 1From: Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapyCorrelation between SUVmax and hematological markers LMR a, NLR b and PLR cBack to article page